euthanasia sodium pentobarbital - An Overview
euthanasia sodium pentobarbital - An Overview
Blog Article
pentobarbital will reduce the extent or impact of diazepam intranasal by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Watch. Sturdy or moderate CYP3A4 inducers may well improve amount of diazepam elimination; as a result, efficacy of diazepam may be lessened.
Right after stopping a CYP3A4 inducer, since the effects of the inducer decrease, the fentanyl plasma concentration will maximize which could raise or extend each the therapeutic and adverse effects.
pentobarbital will minimize the extent or influence of theophylline by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will reduce the level or outcome of pitolisant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Closely. Pitolisant exposure is lowered by 50% if coadministered with powerful CYP3A4 inducers.
pentobarbital will reduce the extent or result of vinblastine by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Insignificant/Significance Unfamiliar.
Remark: Barbiturates may improve adverse effects, together with respiratory depression, made by harmful doses of TCAs. With therapeutic doses of TCAs, barbiturates improve metabolism and decrease blood concentrations of TCAs.
pentobarbital will reduce the extent or effect of elagolix by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor.
pentobarbital decreases amounts of amphotericin B deoxycholate by inhibition of GI absorption. Applies only to oral type of both agents. Minor/Significance Not known.
pentobarbital will lower the extent or outcome of venetoclax by impacting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital will minimize the extent or effect of dexamethasone by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
pentobarbital will decrease the extent or influence of cinacalcet by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep track of.
pentobarbital will reduce the level or influence of buspirone by more info affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.
Contraindicated (one)pentobarbital will minimize the level or result of lonafarnib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib is often a delicate CYP3A4 substrate. Coadministration with potent or average CYP3A4 inducers is contraindicated.
pentobarbital will minimize the extent or effect of sulfamethoxazole by affecting hepatic enzyme CYP2C9/10 metabolism. Minor/Significance Unknown.